相似文献
1
Dengue virus infection in travellers after dengue vaccination, Germany 2023-24.
J Travel Med. 2025 Apr 25;32(4). doi: 10.1093/jtm/taaf037.
2
First clinical experiences with the tetravalent live vaccine against dengue (Qdenga®) in travellers: a multicentric TravVacNet study in Germany.
J Travel Med. 2025 Mar 11;32(2). doi: 10.1093/jtm/taaf004.
3
Dengue in travellers is still underestimated.
Intervirology. 2008;51(2):96-100. doi: 10.1159/000131667. Epub 2008 May 13.
4
Vaccination against dengue fever for travellers.
Swiss Med Wkly. 2024 Sep 19;154:3858. doi: 10.57187/s.3858.
5
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects.
Acta Trop. 2004 Mar;90(1):87-95. doi: 10.1016/j.actatropica.2003.11.004.
6
Dengue, chikungunya and Zika virus infections among Dutch travellers to Suriname: a prospective study during the introduction of chikungunya and Zika virus, 2014 to 2017.
Euro Surveill. 2023 Jan;28(2). doi: 10.2807/1560-7917.ES.2023.28.2.2200344.
7
Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia.
Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1203-10. doi: 10.1007/s10096-011-1429-1. Epub 2011 Oct 9.
8
Increase in dengue fever in travellers returning from Egypt, Germany 2023.
Euro Surveill. 2024 Feb;29(5). doi: 10.2807/1560-7917.ES.2024.29.5.2400042.
9
Incidence of dengue virus infection among Japanese travellers, 2006 to 2010.
Western Pac Surveill Response J. 2012 Jun 8;3(2):39-45. doi: 10.5365/WPSAR.2011.2.3.002. Print 2012 Apr.
10
Severe dengue in travellers: pathogenesis, risk and clinical management.
J Travel Med. 2019 Oct 14;26(7). doi: 10.1093/jtm/taz062.
本文引用的文献
1
Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial.
Vaccine. 2024 Dec 2;42(26):126309. doi: 10.1016/j.vaccine.2024.126309. Epub 2024 Sep 7.
2
IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial.
Am J Trop Med Hyg. 2024 May 28;111(1):102-106. doi: 10.4269/ajtmh.23-0549. Print 2024 Jul 3.
3
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis. 2022 Aug 24;75(1):107-117. doi: 10.1093/cid/ciab864.
4
Dengue, chikungunya and Zika in GeoSentinel surveillance of international travellers: a literature review from 1995 to 2020.
J Travel Med. 2020 Dec 23;27(8). doi: 10.1093/jtm/taaa222.
5
Severe dengue in travellers: pathogenesis, risk and clinical management.
J Travel Med. 2019 Oct 14;26(7). doi: 10.1093/jtm/taz062.
6
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.
Lancet Infect Dis. 2010 Oct;10(10):712-22. doi: 10.1016/S1473-3099(10)70166-3.
Zotero 插件